(Q34496154)

2 August 2017

1 reference

title

The costs of caring: medical costs of Alzheimer's disease and the managed care environment (English)

1 reference

2 August 2017

0 references

D L Murman

1

1 reference

2 August 2017

publication date

1 January 2001

1 reference

Journal of Geriatric Psychiatry and Neurology

2 August 2017

published in

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

168-178

1 reference

The economic burden of Alzheimer's disease care

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Estimated prevalence of Alzheimer's disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The American health care system. Health insurance coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Disease management--promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Alzheimer's disease care: costs and potential savings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The effect of diagnosing Alzheimer’s disease on frequency of physician visits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Hospitalization and Alzheimer's disease: results from a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Cognitive impairment. Can it predict the course of hospitalized patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The cost of institutional care in Alzheimer's disease: nursing home and hospital use in a prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Longitudinal study of death and institutionalization in patients with primary degenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Descriptive analysis of emergency hospital admissions of patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Predicting time to nursing home care and death in individuals with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Predicting 10-year care requirements for older people with suspected Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Impact of the type and severity of dementia on hospitalization and survival of the elderly. The SAGE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The cost of dementia in Denmark: the Odense Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The American health care system--Medicare

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The American health care system--Medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Long-term care for frail elderly people--the On Lok model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Cost of Alzheimer's disease and related dementia in managed-medicare.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Chronic care costs in managed care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

How much do persons with Alzheimer's disease cost Medicare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Managed care in transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Managed competition and California's health care economy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Program of All-inclusive Care for the Elderly (PACE): an innovative model of integrated geriatric care and financing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

S/HMOs, the second generation: building on the experience of the first Social Health Maintenance Organization demonstrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

A concerned optimist: an "exit interview" with Bruce Vladeck, PhD. Interview by Emily Friedman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The Urgent Need to Improve Health Care Quality Institute of Medicine National Roundtable on Health Care Quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Does managed care lead to better or worse quality of care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Donepezil use in managed Medicare: effect on health care costs and utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Evidence-based disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Documentation and evaluation of cognitive impairment in elderly primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Diagnosing dementia: perspectives of primary care physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Mental health services for Alzheimer's disease. Current trends in reimbursement and public policy, and the future under managed care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Caregiving as a risk factor for mortality: the Caregiver Health Effects Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Psychotropic drug use among caregivers of patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

A multicomponent intervention to prevent delirium in hospitalized older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Are methods for estimating QALYs in cost-effectiveness analyses improving?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Analysis and interpretation of cost data in randomised controlled trials: review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

The economic impact of the tacrine in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

An economic evaluation of donepezil in the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

Cost-effectiveness analysis of day care for patients with dementia disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870101400402

10.1177/089198870101400402

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference